1KFF | D:16-132; D:16-132; D:16-132; D:16-132 | AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE: APO-SAM1 |
1KL3 | D:16-132; D:16-132; D:16-132; D:16-132 | AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM1-STREPII |
1KL4 | D:16-132; D:16-132; D:16-132; D:16-132 | AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : APO-SAM2 |
1KL5 | D:16-132; D:16-132; D:16-132; D:16-132 | AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM2-STREPII |
1LCV | B:216-332; B:216-332 | STREPTAVIDIN-NORBIOTIN COMPLEX |
1LCW | B:216-332; B:216-332 | STREPTAVIDIN-HOMOBIOTIN COMPLEX |
1LCZ | B:216-332; B:216-332 | STREPTAVIDIN-BCAP COMPLEX |
1LUQ | B:2016-2132; B:2016-2132 | FULL MATRIX ERROR ANALYSIS OF STREPTAVIDIN |
1MEP | D:16-132; D:16-132; D:16-132; D:16-132 | CRYSTAL STRUCTURE OF STREPTAVIDIN DOUBLE MUTANT S45A/D128A WITH BIOTIN: COOPERATIVE HYDROGEN-BOND INTERACTIONS IN THE STREPTAVIDIN-BIOTIN SYSTEM. |
1MK5 | B:16-132; B:16-132 | WILDTYPE CORE-STREPTAVIDIN WITH BIOTIN AT 1.4A. |
1MM9 | A:16-132 | STREPTAVIDIN MUTANT WITH INSERTION OF FIBRONECTIN HEXAPEPTIDE, INCLUDING RGD |
1MOY | A:16-132 | STREPTAVIDIN MUTANT WITH OSTEOPONTIN HEXAPEPTIDE INSERTION INCLUDING RGD |
1N4J | A:16-132 | STREPTAVIDIN MUTANT N23A AT 2.18A |
1N7Y | D:16-132; D:16-132; D:16-132; D:16-132 | STREPTAVIDIN MUTANT N23E AT 1.96A |
1N9M | D:15-132; D:15-132; D:15-132; D:15-132 | STREPTAVIDIN MUTANT S27A WITH BIOTIN AT 1.6A RESOLUTION |
1N9Y | D:16-132; D:16-132; D:16-132; D:16-132 | STREPTAVIDIN MUTANT S27A AT 1.5A RESOLUTION |
1NBX | D:16-132; D:16-132; D:16-132; D:16-132 | STREPTAVIDIN MUTANT Y43A AT 1.70A RESOLUTION |
1NC9 | D:16-132; D:16-132; D:16-132; D:16-132 | STREPTAVIDIN MUTANT Y43A WITH IMINOBIOTIN AT 1.8A RESOLUTION |
1NDJ | D:16-132; D:16-132; D:16-132; D:16-132 | STREPTAVIDIN MUTANT Y43F WITH BIOTIN AT 1.81A RESOLUTION |
1NQM | D:616-732; D:616-732; D:616-732; D:616-732 | STRUCTURE OF SAVM-W120K, STREPTAVIDIN MUTANT |
1RST | B:15-132 | COMPLEX BETWEEN STREPTAVIDIN AND THE STREP-TAG PEPTIDE |
1RSU | B:15-132 | COMPLEX BETWEEN STREPTAVIDIN AND THE STREP-TAG II PEPTIDE |
1RXH | B:215-332; B:215-332 | CRYSTAL STRUCTURE OF STREPTAVIDIN MUTANT L124R (M1) COMPLEXED WITH BIOTINYL P-NITROANILIDE (BNI) |
1RXK | B:15-132; B:15-132 | CRYSTAL STRUCTURE OF STREPTAVIDIN MUTANT (M3) A COMBINATION OF M1+M2 |
1SLD | B:15-132 | STREPTAVIDIN, PH 7.5, BOUND TO CYCLIC DISULFIDE-BONDED PEPTIDE LIGAND AC-CHPQFC-NH2 |
1SLE | D:15-132; D:15-132 | STREPTAVIDIN, PH 5.0, BOUND TO CYCLIC PEPTIDE AC-CHPQGPPC-NH2 |
1SLF | D:15-132; D:15-132 | APOSTREPTAVIDIN, PH 5.6, TWO MOLECULES OF (SO4)2 BOUND AT THE BIOTIN BINDING SITE |
1SLG | D:15-132; D:15-132 | STREPTAVIDIN, PH 5.6, BOUND TO PEPTIDE FCHPQNT |
1SRE | B:15-132; B:15-132 | CRYSTALLOGRAPHIC AND THERMODYNAMIC COMPARISON OF NATURAL AND SYNTHETIC LIGANDS BOUND TO STREPTAVIDIN |
1SRG | B:15-132; B:15-132 | STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDIN |
1SRH | B:15-132; B:15-132 | STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDIN |
1SRI | B:15-132; B:15-132 | STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDIN |
1SRJ | B:15-132; B:15-132 | STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDIN |
1STP | A:15-132 | STRUCTURAL ORIGINS OF HIGH-AFFINITY BIOTIN BINDING TO STREPTAVIDIN |
1STR | D:15-132; D:15-132 | STREPTAVIDIN DIMERIZED BY DISULFIDE-BONDED PEPTIDE AC-CHPQNT-NH2 DIMER |
1STS | D:15-132; D:15-132 | STREPTAVIDIN DIMERIZED BY DISULFIDE-BONDED PEPTIDE FCHPQNT-NH2 DIMER |
1SWA | D:16-132; D:16-132; D:16-132; D:16-132 | APO-CORE-STREPTAVIDIN AT PH 4.5 |
1SWB | D:16-132; D:16-132; D:16-132; D:16-132 | APO-CORE-STREPTAVIDIN AT PH 7.5 |
1SWC | D:16-132; D:16-132; D:16-132; D:16-132 | APO-CORE-STREPTAVIDIN AT PH 4.5 |
1SWD | D:16-132; D:16-132; D:16-132; D:16-132 | APO-CORE-STREPTAVIDIN IN COMPLEX WITH BIOTIN (TWO UNOCCUPIED BINDING SITES) AT PH 4.5 |
1SWE | D:16-132; D:16-132; D:16-132; D:16-132 | APO-CORE-STREPTAVIDIN IN COMPLEX WITH BIOTIN AT PH 4.5 |
1SWF | D:52-132; D:52-132; D:52-132; D:52-132 | CIRCULAR PERMUTED STREPTAVIDIN E51/A46 |
1SWG | D:51-132; D:51-132; D:51-132; D:51-132 | CIRCULAR PERMUTED STREPTAVIDIN E51/A46 IN COMPLEX WITH BIOTIN |
1SWH | D:16-132; D:16-132; D:16-132; D:16-132 | CORE-STREPTAVIDIN MUTANT W79F AT PH 4.5 |
1SWK | D:16-132; D:16-132; D:16-132; D:16-132 | CORE-STREPTAVIDIN MUTANT W79F IN COMPLEX WITH BIOTIN AT PH 4.5 |
1SWN | D:16-132; D:16-132; D:16-132; D:16-132 | CORE-STREPTAVIDIN MUTANT W108F IN COMPLEX WITH BIOTIN AT PH 7.0 |
1SWO | D:16-132; D:16-132; D:16-132; D:16-132 | CORE-STREPTAVIDIN MUTANT W120F AT PH 7.5 |
1SWQ | D:16-132; D:16-132; D:16-132; D:16-132 | CORE-STREPTAVIDIN MUTANT W120A AT PH 7.5 |
1SWR | D:16-132; D:16-132; D:16-132; D:16-132 | CORE-STREPTAVIDIN MUTANT W120A IN COMPLEX WITH BIOTIN AT PH 7.5 |
1SWS | D:16-132; D:16-132; D:16-132; D:16-132 | CORE-STREPTAVIDIN MUTANT D128A AT PH 4.5 |
1SWU | D:16-132; D:16-132; D:16-132; D:16-132 | STREPTAVIDIN MUTANT Y43F |
1VWA | D:15-132; D:15-132 | STREPTAVIDIN-FSHPQNT |
1VWB | B:15-132 | STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 11.8 |
1VWC | B:15-132 | STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 2.0 |
1VWD | B:15-132 | STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 3.0 |
1VWE | B:15-132 | STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 3.6 |
1VWG | B:15-132 | STREPTAVIDIN COMPLEXED WITH THE HEAD-TO-TAIL DISULFIDE-BONDED PEPTIDE DIMER OF CYCLO-AC-[CHPQGPPC]-NH2, PH 2.5 |
1VWH | B:15-132 | STREPTAVIDIN COMPLEXED WITH THE HEAD-TO-TAIL DISULFIDE-BONDED PEPTIDE DIMER OF CYCLO-AC-[CHPQGPPC]-NH2, PH 3.5 |
1VWI | D:15-132; D:15-132 | STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 1.5, I222 COMPLEX |
1VWJ | D:15-132; D:15-132 | STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 2.5, I222 COMPLEX |
1VWK | D:15-132; D:15-132 | STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2 |
1VWL | D:15-132; D:15-132 | STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 3.5, I222 COMPLEX |
1VWM | B:15-132 | STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 4.2 |
1VWN | B:15-132 | STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 4.8 |
1VWO | B:15-132 | STREPTAVIDIN COMPLEXED WITH CYCLO-AC-[CHPQGPPC]-NH2 MONOMER, PH 2.85 |
1VWP | B:15-132 | STREPTAVIDIN COMPLEXED WITH CYCLO-AC-[CHPQGPPC]-NH2 MONOMER, PH 2.5 |
1VWQ | B:15-132 | STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 2.5, I4122 COMPLEX |
1VWR | B:15-132 | STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 3.5, I4122 COMPLEX |
2QCB | A:15-132 | T7-TAGGED FULL-LENGTH STREPTAVIDIN COMPLEXED WITH RUTHENIUM LIGAND |
2RTB | D:15-132; D:15-132 | APOSTREPTAVIDIN, PH 3.32, SPACE GROUP I222 |
2RTC | D:15-132; D:15-132 | APOSTREPTAVIDIN, PH 3.60, SPACE GROUP I222 |
2RTD | D:15-132; D:15-132 | STREPTAVIDIN-BIOTIN COMPLEX, PH 1.39, SPACE GROUP I222 |
2RTE | D:15-132; D:15-132 | STREPTAVIDIN-BIOTIN COMPLEX, PH 1.90, SPACE GROUP I222 |
2RTF | D:15-132; D:15-132 | STREPTAVIDIN-BIOTIN COMPLEX, PH 2.00, SPACE GROUP I222 |
2RTH | D:15-132; D:15-132 | STREPTAVIDIN-GLYCOLURIL COMPLEX, PH 2.50, SPACE GROUP I222 |
2RTI | D:15-132; D:15-132 | STREPTAVIDIN-GLYCOLURIL COMPLEX, PH 2.50, SPACE GROUP I222 |
2RTJ | A:15-132 | STREPTAVIDIN-GLYCOLURIL COMPLEX, PH 2.50, SPACE GROUP I4122 |
2RTK | A:15-132 | STREPTAVIDIN-GLYCOLURIL COMPLEX, PH 2.58, SPACE GROUP I4122 PREPARED FROM AN APOSTREPTAVIDIN CRYSTAL |
2RTL | A:15-132 | STREPTAVIDIN-2-IMINOBIOTIN-SULFATE COMPLEX, PH 2.50, SPACE GROUP I4122 |
2RTM | A:15-132 | STREPTAVIDIN-2-IMINOBIOTIN-SULFATE COMPLEX, PH 3.50, SPACE GROUP I4122 |
2RTN | D:15-132; D:15-132 | STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 2.0, SPACE GROUP I222 |
2RTO | D:15-132; D:15-132 | STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 2.6, SPACE GROUP I222 |
2RTQ | D:15-132; D:15-132 | STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 3.25, SPACE GROUP I222, CRYSTALLIZED FROM 4.3 M AMMONIUM SULFATE |
2RTR | D:15-132; D:15-132 | STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 4.0, SPACE GROUP I222 |
2WPU | A:15-132 | CHAPERONED RUTHENIUM METALLODRUGS THAT RECOGNIZE TELOMERIC DNA |
2Y3E | B:16-132; B:16-132 | TRAPTAVIDIN, APO-FORM |
2Y3F | A:15-132 | TRAPTAVIDIN, BIOTIN BOUND FORM |
3MG5 | D:16-132; D:16-132; D:16-132; D:16-132 | CORE-STREPTAVIDIN MUTANT F130L IN COMPLEX WITH BIOTIN |
3PK2 | A:15-132 | ARTIFICIAL TRANSFER HYDROGENASES FOR THE ENANTIOSELECTIVE REDUCTION OF CYCLIC IMINES |
3RDM | A:28-145 | CRYSTAL STRUCTURE OF R7-2 STREPTAVIDIN COMPLEXED WITH BIOTIN/PEG |
3RDO | A:15-132 | CRYSTAL STRUCTURE OF R7-2 STREPTAVIDIN COMPLEXED WITH BIOTIN |
3RDQ | A:15-132 | CRYSTAL STRUCTURE OF R7-2 STREPTAVIDIN COMPLEXED WITH DESTHIOBIOTIN |
3RDS | A:15-132 | CRYSTAL STRUCTURE OF THE REFOLDED R7-2 STREPTAVIDIN |
3RDU | A:15-132 | CRYSTAL STRUCTURE OF R7-2 STREPTAVIDIN COMPLEXED WITH PEG |
3RDX | B:15-132; B:15-132 | CRYSTAL STRUCTURE OF LIGAND-FREE R7-2 STREPTAVIDIN |
3RE5 | A:15-132 | CRYSTAL STRUCTURE OF R4-6 STREPTAVIDIN |
3RE6 | A:15-132 | CRYSTAL STRUCTURE OF R4-6 STREPTAVIDIN |